Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access
Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access
Bloomberg Law | Jan 13, 2022
Recent Posts
- Jane Lynch to be Honored with Global Down Syndrome Foundation’s Most Prestigious Award
- Global Down Syndrome Foundation Invests $1.3 Million, Empowers Game-Changing Local Programs
- In Loving Memory: A Tribute to Lorraine Pope
- GLOBAL Recap of 2025 NDSC Annual Convention in Dallas
- Exclusive Interview with Down Syndrome Association of Middle Tennessee Executive Director Alecia Talbott